EVEREST MED (01952) Sets 25 March 2026 Board Meeting to Approve FY 2025 Results

Bulletin Express

03/10

Everest Medicines Limited (stock code: 01952; abbreviated as EVEREST MED) has scheduled a board meeting for 25 March 2026. The session will focus on reviewing and approving the Group’s audited annual results for the financial year ended 31 December 2025, along with other corporate matters.

The current Board comprises: • Chairman and Executive Director: Yifang Wu • Executive Directors: Yongqing Luo, Ian Ying Woo • Non-executive Directors: Wei Fu, William Ki Chul Cho, Xin Sun • Independent Non-executive Directors: Hoi Yam Chui, Yifan Li, Shidong Jiang

The announcement was released in Hong Kong on 10 March 2026 and filed with Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1127952348"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1127952348\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1127952348?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-10 17:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1127952348","market":"us","top_or_hot":-1,"title":"EVEREST MED (01952) Sets 25 March 2026 Board Meeting to Approve FY 2025 Results","media":"Bulletin Express","content":"<p>Everest Medicines Limited (stock code: 01952; abbreviated as EVEREST MED) has scheduled a board meeting for 25 March 2026. The session will focus on reviewing and approving the Group’s audited annual results for the financial year ended 31 December 2025, along with other corporate matters.</p>\n<p>The current Board comprises:\n• Chairman and Executive Director: Yifang Wu  \n• Executive Directors: Yongqing Luo, Ian Ying Woo  \n• Non-executive Directors: Wei Fu, William Ki Chul Cho, Xin Sun  \n• Independent Non-executive Directors: Hoi Yam Chui, Yifan Li, Shidong Jiang</p>\n<p>The announcement was released in Hong Kong on 10 March 2026 and filed with Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EVEREST MED (01952) Sets 25 March 2026 Board Meeting to Approve FY 2025 Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEVEREST MED (01952) Sets 25 March 2026 Board Meeting to Approve FY 2025 Results\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2026-03-10 17:03</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Everest Medicines Limited (stock code: 01952; abbreviated as EVEREST MED) has scheduled a board meeting for 25 March 2026. The session will focus on reviewing and approving the Group’s audited annual results for the financial year ended 31 December 2025, along with other corporate matters.</p>\n<p>The current Board comprises:\n• Chairman and Executive Director: Yifang Wu  \n• Executive Directors: Yongqing Luo, Ian Ying Woo  \n• Non-executive Directors: Wei Fu, William Ki Chul Cho, Xin Sun  \n• Independent Non-executive Directors: Hoi Yam Chui, Yifan Li, Shidong Jiang</p>\n<p>The announcement was released in Hong Kong on 10 March 2026 and filed with Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01952","symbol_name":"雲頂新耀","start_time":0,"source_url":"","article_id":"1127952348","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1127952348","pubTimestamp":1773133437,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Everest Medicines Limited (stock code: 01952; abbreviated as EVEREST MED) has scheduled a board meeting for 25 March 2026. The session will focus on reviewing and approving the Group’s audited annual...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01952":"云顶新耀"},"translate_title":"EVEREST MED(01952)定于2026年3月25日召开董事会批准2025财年业绩","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01952":1},"content_text":"Everest Medicines Limited (stock code: 01952; abbreviated as EVEREST MED) has scheduled a board meeting for 25 March 2026. The session will focus on reviewing and approving the Group’s audited annual results for the financial year ended 31 December 2025, along with other corporate matters.\nThe current Board comprises:\n• Chairman and Executive Director: Yifang Wu  \n• Executive Directors: Yongqing Luo, Ian Ying Woo  \n• Non-executive Directors: Wei Fu, William Ki Chul Cho, Xin Sun  \n• Independent Non-executive Directors: Hoi Yam Chui, Yifan Li, Shidong Jiang\nThe announcement was released in Hong Kong on 10 March 2026 and filed with Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}